maprounic acid has been researched along with oleanolic acid in 4 studies
Studies (maprounic acid) | Trials (maprounic acid) | Recent Studies (post-2010) (maprounic acid) | Studies (oleanolic acid) | Trials (oleanolic acid) | Recent Studies (post-2010) (oleanolic acid) |
---|---|---|---|---|---|
15 | 0 | 8 | 4,169 | 31 | 2,404 |
Protein | Taxonomy | maprounic acid (IC50) | oleanolic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.045 | |
Phospholipase A2 | Homo sapiens (human) | 3 | |
DNA polymerase beta | Homo sapiens (human) | 6.8667 | |
DNA polymerase beta | Rattus norvegicus (Norway rat) | 5.6 | |
Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | 1 | |
Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | 3.065 | |
Tissue factor | Homo sapiens (human) | 0.005 | |
Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 4.38 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.8444 | |
Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 | |
Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.065 | |
M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.98 | |
Dual specificity protein phosphatase 3 | Homo sapiens (human) | 5.4 | |
Transcription factor p65 | Homo sapiens (human) | 2.4 | |
Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.065 | |
Protease | Human immunodeficiency virus 1 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chin, YW; Jee, JG; Jeong, YJ; Keum, YS; Kim, Y; Lee, J; Lee, JM; Yu, MS | 1 |
Ahn, HC; Cho, SC; Choi, BY; Fei, X; Keum, YS; Kim, HJ; Lee, K; Seo, SY | 1 |
Ansari, MI; Coop, A; Johnson, CR; Kamil Hussain, M; Khatoon, S; Saquib, M | 1 |
Liu, XK; Qing, C; Wu, DG; Yang, SM; Zhu, DY | 1 |
1 review(s) available for maprounic acid and oleanolic acid
Article | Year |
---|---|
Recent advances in the targeting of human DNA ligase I as a potential new strategy for cancer treatment.
Topics: Antineoplastic Agents; Cell Proliferation; DNA Ligase ATP; Enzyme Inhibitors; Humans; Neoplasms; Structure-Activity Relationship | 2019 |
3 other study(ies) available for maprounic acid and oleanolic acid
Article | Year |
---|---|
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
Topics: Adenosine Triphosphate; Antiviral Agents; Apigenin; Breast; Cell Line; Cell Proliferation; Colorimetry; DNA; DNA Helicases; Epithelial Cells; Female; Flavonoids; Fluorescence Resonance Energy Transfer; Hepacivirus; Humans; Hydrolysis; Inhibitory Concentration 50; Kinetics; Methyltransferases; RNA Helicases; Severe acute respiratory syndrome-related coronavirus; Species Specificity; Viral Nonstructural Proteins; Viral Proteins | 2012 |
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
Topics: Binding, Competitive; Drug Discovery; Humans; Isocitrate Dehydrogenase; MCF-7 Cells; Molecular Structure; Mutation; Recombinant Proteins; Structure-Activity Relationship; Xanthones | 2015 |
Chemical constituents from the roots of Homonoia riparia.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Coumarins; Dioxanes; Euphorbiaceae; Humans; Inhibitory Concentration 50; Molecular Structure; Oleanolic Acid; Palmitic Acids; Plant Roots; Plants, Medicinal; Triterpenes | 2007 |